Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.76
-0.28 (-3.98%)
At close: Sep 12, 2025, 4:00 PM EDT
6.93
+0.17 (2.56%)
After-hours: Sep 12, 2025, 7:22 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $219.85 million as of September 12, 2025. Its market cap has increased by 126.60% in one year.
Market Cap
219.85M
Enterprise Value
84.53M
1-Year Change
126.60%
Ranking
Category
Stock Price
$6.76
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $219.85M, a decrease of -38.04%. That is a compound annual growth rate of -19.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 219.85M | 51.74% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |